Changing epidemiology of intussusception in Australia

Objectives:  Oral rotavirus vaccines are expected to become available in Australia within the next 2 years. In light of evidence for an association between a rotavirus vaccine and intussusception, it is important to define the baseline epidemiology of intussusception in Australia and establish a system for intussusception surveillance in the immediate post‐licensure period. This study reports on incidence and epidemiology of intussusception in Australia.

[1]  J. Bines Rotavirus vaccines and intussusception risk , 2005, Current opinion in gastroenterology.

[2]  K. Mulholland,et al.  Clinical Case Definition for the Diagnosis of Acute Intussusception , 2004, Journal of pediatric gastroenterology and nutrition.

[3]  M. Melbye,et al.  Intussusception in Early Childhood: A Cohort Study of 1.7 Million Children , 2004, Pediatrics.

[4]  R. Glass,et al.  The future of rotavirus vaccines: a major setback leads to new opportunities , 2004, The Lancet.

[5]  E. Palombo,et al.  Genetic and Antigenic Characterization of Rotavirus Serotype G9 Strains Isolated in Australia between 1997 and 2001 , 2003, Journal of Clinical Microbiology.

[6]  Mark A. Miller,et al.  Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.

[7]  Benjamin Schwartz,et al.  The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. , 2003, The Journal of infectious diseases.

[8]  R. Chanock,et al.  Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. , 2003, The Journal of infectious diseases.

[9]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.

[10]  G. Barnes,et al.  Annual report of the Rotavirus Surveillance Programme, 1999/2000. , 2000, Communicable diseases intelligence.

[11]  N. Dakum,et al.  Childhood intussusception: a 9-year review , 2000, Annals of tropical paediatrics.

[12]  J. Carlin,et al.  Cost effectiveness of rotavirus vaccination in Australia , 1999, Australian and New Zealand journal of public health.

[13]  S. M. Hewitt,et al.  Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1999, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[14]  J. Carlin,et al.  Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993–1996 , 1998, The Medical journal of Australia.

[15]  X. Pang,et al.  Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis , 1997, The Lancet.

[16]  A. Kapikian,et al.  Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. , 1997, The New England journal of medicine.

[17]  S. Perry Reports from the Australian Institute of Health and Welfare (AIHW) , 1995, International Journal of Technology Assessment in Health Care.

[18]  H. K. Goon,et al.  Intussusception among infants and children in Malaysia. , 1982, The Medical journal of Malaysia.

[19]  T. Solanke Intestinal obstruction in Ibadan. , 1968, The West African medical journal and Nigerian practitioner.

[20]  E. J. Donovan,et al.  Acute Intussusception in Infants and Children. , 1946, Annals of surgery.